Related Experiment Video
Updated: Aug 6, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
STING-mediated cancer immunotherapy: emerging modalities and beyond
Ramesha Hanumanthappa1, Nandakumar Dalavaikodihalli Nanjaiah2, Sudhir H Ranganath1
1Bio-INvENT Lab, Department of Chemical Engineering, Siddaganga Institute of Technology, Tumkur, Karnataka, India.
Trends in Pharmacological Sciences
|July 25, 2026
Summary
New strategies precisely control stimulator of interferon genes (STING) activation for safer, more effective cancer immunotherapy, overcoming immune exhaustion and toxicity for better clinical translation.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Clinical translation of STING agonist cancer immunotherapy is hindered by uncontrolled STING activation.
- Sustained STING activation leads to immune exhaustion and systemic toxicity, limiting therapeutic efficacy.
Purpose of the Study:
- To critically analyze recent advances in precise spatiotemporal STING activation systems.
- To identify gaps in the clinical translation of these advanced STING-based immunotherapies.
- To present future perspectives on next-generation STING immunotherapy.
Main Methods:
- Review of stimuli-responsive, biomimetic, pulsatile, and intracellular-triggered release systems.
- Analysis of synergistic approaches for enhanced STING activation.
- Evaluation of current challenges and future directions in clinical translation.
Main Results:
- Development of advanced systems for controlled STING activation, including stimuli-responsive and biomimetic designs.
- Identification of synergistic strategies to improve therapeutic outcomes.
- Highlighting significant gaps in translating these precise activation systems into clinical practice.
Conclusions:
- Precise spatiotemporal STING activation is crucial for overcoming limitations in current cancer immunotherapy.
- Advanced delivery systems and synergistic approaches show promise for next-generation STING-based therapies.
- Addressing clinical translation gaps is essential for realizing the full potential of STING agonists in oncology.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...